Steffany Shearer
MOHS-Micrographic Surgery · Raleigh, NCNPI 1912250499
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.7% of the total. Reporting peaked in 2019 at $2,103 and has fallen 96.4% since, to $76 in 2024.
Across 237 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$779
- Sun Pharmaceutical Industries Inc.$408
- Novartis$276
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$244
- Pfizer$225
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$4509%
- Food & beverage$4,55791%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $1,387 |
| Galderma Laboratories, L.p. | 17 | $779 |
| Sun Pharmaceutical Industries Inc. | 22 | $408 |
| Novartis | 20 | $276 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 15 | $244 |
| Pfizer | 16 | $225 |
| Mayne Pharma Commercial LLC | 9 | $211 |
| LEO Pharma Inc. | 15 | $203 |
| Amgen | 8 | $182 |
| Sanofi | 5 | $135 |
| Lilly USA, LLC | 8 | $135 |
| Johnson & Johnson | 6 | $131 |
| Regeneron Healthcare Solutions, Inc. | 6 | $126 |
| UCB, Inc. | 6 | $119 |
| Almirall LLC | 4 | $78 |
| EPI Health, LLC | 4 | $65 |
| Genentech USA, Inc. | 3 | $53 |
| Aclaris Therapeutics, Inc. | 2 | $40 |
| VYNE Pharmaceuticals Inc. | 2 | $39 |
| DUSA Pharmaceuticals, Inc. | 2 | $34 |
| Bristol Myers Squibb | 1 | $26 |
| Incyte Corporation | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Mission Pharmacal Company | 1 | $20 |
| Merck | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$127
- Humira$125
- DORYX$113
How this compares
$5,007 in reported general payments places this provider in the 85th percentile of 50 mohs-micrographic surgery providers in North Carolina.
See all mohs-micrographic surgery providers in North Carolina →
Other mohs-micrographic surgery in Raleigh
- Eric ChallgrenRaleigh$47K
- Gregory WilmothRaleigh$8K
- Audrey EchtRaleigh$4K
- Fernando PuenteRaleigh$3K
- Lindsay OsbornRaleigh$678
- Harold RabinovitzRaleigh$623
- Earl BainRaleigh$361
- Tamara HousmanRaleigh$330
- Girish MunavalliCharlotte$118K
- Laura RosenzweigCharlotte$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.